Kyowa Kirin Co., Ltd.

Pharmaceuticals

Company Summary

Kyowa Kirin Co., Ltd. develops and distributes medications for oncology, nephrology, the central nervous system, and immunology around the world. The company's headquarters are in Tokyo, Japan, where it was formed in 1949.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

28
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E1.6S15.6G11.1

Refinitiv

Overall ESG Rating :

65
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E61S65G68

Overall ESG Rating :

A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Kyowa Kirin is average among 86 companies in the pharmaceuticals industry.

Temperature Rise :

1.83℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned